SECARE — Swedencare AB (publ) Share Price
Last trade - 00:00- SEK5.68bn
- SEK6.96bn
- SEK2.54bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 24.2 | ||
| PEG Ratio (f) | 0.62 | ||
| EPS Growth (f) | 64.69% | ||
| Dividend Yield (f) | 1.47% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.71 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 19.73 | ||
| Price to Sales | 2.24 | ||
| EV to EBITDA | 12.87 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.27% | ||
| Return on Equity | 1.3% | ||
| Operating Margin | 8.86% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 240.29 | 773.21 | 1,834.32 | 2,338.3 | 2,539.9 | 2,803 | 3,094.75 | 82.09% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +1.36 | +27.21 | +24.45 | -31.03 | +67.93 | +85.87 | +40.23 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Swedencare AB (publ) is a Sweden-based company which is mainly involved in the veterinary supplies industry. The company scope of activity includes manufacturing, developing and sale of products in the field of animal health care and preventive dental care products made of seaweed selected cold North Atlantic waters off the Scandinavian coastline. The Company operates as a provider of various products for animal health, distributed to veterinarians, pet stores as well as pharmacies. The Company's product portfolio includes ProDen product family, which consists of ProDen PlaqueOff Teeth and Gums, ProDen PlaqueOff Dental Bites, among others. The products are available at veterinary clinics, pet retailers, pharmacies, health stores and dentist practices.
Directors
- Per Malmstroem CHM (60)
- Hakan Lagerberg CEO (53)
- Jenny Graflind CFO (45)
- Jason Braun CEX (51)
- Ed Holden CEX (40)
- John Leonard CEX (56)
- Brian Nugent CEX (47)
- Hans-Ake Persson CEX (70)
- Ioanna Psychogiou CEX (36)
- Matthew Shaw CEX (37)
- Martin Shimko CEX (57)
- Raquel Tosca OTH (47)
- Sabine Uhde OTH (51)
- Johan Bergdahl DRC (51)
- Hakan Svanberg DRC (64)
- Sara Brandt IND (58)
- Thomas Eklund IND (54)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 8th, 1993
- Public Since
- June 14th, 2016
- No. of Shareholders
- 9,492
- No. of Employees
- 579
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 158,862,839
- Address
- Per Albin Hanssons Vag 41, MALMO, 214 32
- Web
- Phone
- +46 4085933
- Auditors
- Deloitte AB
Latest News for SECARE
Upcoming Events for SECARE
Swedencare AB (publ) Nordea Nordic Focus Day
Q2 2025 Swedencare AB (publ) Earnings Release
Q3 2025 Swedencare AB (publ) Earnings Release
Similar to SECARE
Biogaia AB
OMX Nordic Exchange Stockholm
BoneSupport Holding AB
OMX Nordic Exchange Stockholm
Camurus AB
OMX Nordic Exchange Stockholm
Cinclus Pharma Holding publ AB
OMX Nordic Exchange Stockholm
Corline Biomedical AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 23:32 UTC, shares in Swedencare AB (publ) are trading at SEK35.75. This share price information is delayed by 15 minutes.
Shares in Swedencare AB (publ) last closed at SEK35.75 and the price had moved by -34.58% over the past 365 days. In terms of relative price strength the Swedencare AB (publ) share price has underperformed the FTSE Global All Cap Index by -36.22% over the past year.
The overall consensus recommendation for Swedencare AB (publ) is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Swedencare AB (publ) dividend yield is 0.7% based on the trailing twelve month period.
Last year, Swedencare AB (publ) paid a total dividend of SEK0.25, and it currently has a trailing dividend yield of 0.7%.Looking ahead, the next dividend pay date is 2025-05-02.
We do not have data on when Swedencare AB (publ) is to next pay dividends. The historic dividend yield on Swedencare AB (publ) shares is currently 0.7%.
To buy shares in Swedencare AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK35.75, shares in Swedencare AB (publ) had a market capitalisation of SEK5.68bn.
Here are the trading details for Swedencare AB (publ):
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: SECARE
Based on an overall assessment of its quality, value and momentum Swedencare AB (publ) is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Swedencare AB (publ) is SEK53.33. That is 49.17% above the last closing price of SEK35.75.
Analysts covering Swedencare AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of SEK1.31 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Swedencare AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -22.99%.
As of the last closing price of SEK35.75, shares in Swedencare AB (publ) were trading -19.6% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Swedencare AB (publ) PE ratio based on its reported earnings over the past 12 months is 24.2. The shares last closed at SEK35.75.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Swedencare AB (publ)'s management team is headed by:
- Per Malmstroem - CHM
- Hakan Lagerberg - CEO
- Jenny Graflind - CFO
- Jason Braun - CEX
- Ed Holden - CEX
- John Leonard - CEX
- Brian Nugent - CEX
- Hans-Ake Persson - CEX
- Ioanna Psychogiou - CEX
- Matthew Shaw - CEX
- Martin Shimko - CEX
- Raquel Tosca - OTH
- Sabine Uhde - OTH
- Johan Bergdahl - DRC
- Hakan Svanberg - DRC
- Sara Brandt - IND
- Thomas Eklund - IND